Page last updated: 2024-09-04

levofloxacin and Tuberculosis

levofloxacin has been researched along with Tuberculosis in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (8.47)	18.2507
2000's	13 (22.03)	29.6817
2010's	25 (42.37)	24.3611
2020's	16 (27.12)	2.80

Authors

Authors	Studies
Ackerman, M; Cynamon, MH; Pucci, MJ; Shoen, CM; Thanassi, JA	1
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R	1
Blackman, A; Cáceres, T; Cachay, R; Gotuzzo, E; Maruri, F; Meza, E; Schwalb, A; Sterling, TR	1
Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J	1
Dodd, PJ; Mafirakureva, N; McQuaid, CF; Seddon, JA	1
Chariyavilaskul, P; Jantarabenjakul, W; Moonwong, J; Phaisal, W; Puthanakit, T; Sudjaritruk, T; Suntarattiwong, P; Supradish Na Ayudhya, P; Tawan, M; Wacharachaisurapol, N	1
He, Y; Li, X	1
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N	1
Alghamdi, WA; Alsultan, A; Peloquin, C	1
Bulychev, VV; Bulycheva, EV; Pashkova, NA	1
Aalhoul, F; Cotton, F; Fage, D	1
Caleffi-Ferracioli, KR; Cardoso, RF; Costacurta, GF; da Silva, LA; de Almeida, AL; de Pádua, RA; do Prado, SM; Ghiraldi Lopes, LD; Ieque, AL; Leal, DC; Micheletti, DF; Sampiron, EG; Santos, NCS; Scodro, RBL; Siqueira, VL	1
Bagai, S; Gupta, KL; Kohli, HS; Kumar, H; Kumar, V; Muthu, V; Nayak, S; Ramachandran, R; Rathi, M; Sharma, A	1
Chavda, J; Ghetiya, R; Shah, S; Soniwala, M	1
Draper, HR; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; van der Laan, LE; Winckler, JL	1
Chaudhary, S; Garg, V; Maji, S; Singh, V	1
Davies, GR; Peloquin, CA	1
Dong, YJ; Gao, MQ; Huang, YX; Li, Q; Ma, LP; Yang, Q	1
Jung, BH; Lee, SG; Park, JI	1
Aktoğu Özkan, S; Biçmen, C; Çavuşoğlu, C; Eraç, B; Ermertcan, Ş; Hoşgör Limoncu, M; Yılmaz, FF	1
Ahmad, Z; Grosset, JH; Minkowski, A; Nuermberger, EL; Peloquin, CA; Tyagi, S	1
Bian, A; Blackman, A; Eden, S; Maruri, F; Mitchel, E; Shintani, AK; Sterling, TR; van der Heijden, YF; Warkentin, JV	1
Cataldi, AA; Di Giulio, AB; Imperiale, BR; Morcillo, NS; Zumárraga, MJ	1
Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A	1
Caleffi-Ferracioli, KR; Cardoso, RF; Maltempe, FG; Siqueira, VL	1
Jeong, BH; Koh, WJ; Kwon, YS	1
Adrián Cataldi, A; Di Giulio, ÁB; Imperiale, BR; Morcillo, NS	1
Ryoken, N	1
Aguado, JM; Blanes, M; Cordero, E; Fariñas, MC; Herrero, JI; López-Ruz, MA; Martín-Dávila, P; Miguez, E; Montejo, M; Muñoz, P; Muñoz-Sanz, A; Rodrigo, J; Rosso-Fernández, CM; San-Juan, R; Silva, JT; Torre-Cisneros, J; Vidal, E	1
Aguado, JM; Torre-Cisneros, J	1
Callister, D; Ho, DY; Lutchman, G; Robilotti, E; Subramanian, A; Tien, V	1
Ajbani, K; Catanzaro, A; Georghiou, SB; Kambli, P; Khillari, A; Nikam, C; Rodrigues, C; Rodwell, TC; Shetty, A; Udwadia, Z	1
Choi, JH; Heo, NY; Jo, KM; Kim, WG; Nam, KH; Park, CS; Park, SH	1
de Gouveia, L; du Plessis, M; Klugman, KP; von Gottberg, A; Wolter, N	1
Chen, YC; Ho, CC; Hu, FC; Luh, KT; Yang, PC; Yu, CJ	1
Bonato, D; Desmond, E; Gross, W; Lin, SY; Siddiqi, S	1
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A	1
Cremades, R; Galiana, A; García-Pachón, E; López, P; Rodríguez, JC; Royo, G; Ruiz-García, M	1
Akagawa, S; Ariga, H; Kaneko, Y; Kawabe, Y; Kawashima, M; Kunogi, M; Machida, K; Masuda, K; Matsui, H; Matsui, Y; Nagai, H; Nagayama, N; Nakajima, Y; Ohshima, N; Shimada, M; Suzuki, J; Tamura, A; Toyota, E	1
Aubry, A; Bastian, S; Brossier, F; Jarlier, V; Mayer, C; Pantel, A; Petrella, S; Veziris, N	1
Bugaenko, SE; Elistratova, NA; Maliev, BM; Mozhokina, GN; Sokolova, GB; Solov'eva, IP	1
Du, Q; Fu, Y; Huang, H; Li, W; Liang, Q; Long, Q; Xie, J	1
López, M; Rodríguez, JC; Royo, G; Ruiz, M	1
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA	1
Chan, EW; Chan, RC; Cheng, AF; Chin, ML; Hui, MM; Yew, WW	1
Bhusal, Y; Shiohira, CM; Yamane, N	1
Elwood, RK; FitzGerald, JM; Marra, CA; Marra, F; Moadebi, S; Shi, P; Stark, G	1
De Souza, MV; Junior, IN; Lourenço, MC	1
Grosset, J; JI, B; Lounis, N; Truffot-Pernot, C	1
Bermudez, LE; Kolonoski, P; Young, LS	1
Akaki, T; Kawahara, S; Sato, K; Shimizu, T; Tomioka, H	1
Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE	1
Akaki, T; Sato, K; Tomioka, H	1
Akaki, T; Kawahara, S; Sato, K; Tomioka, H	1
Duan, L; Lu, Y; Zhu, L	1
Lou, HX; McKaveney, TP; Shullo, MA	1

Reviews

5 review(s) available for levofloxacin and Tuberculosis

Article	Year
The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis. Medicine, 2022, Sep-23, Volume: 101, Issue:38 Topics: Antitubercular Agents; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Network Meta-Analysis; Tuberculosis; Tuberculosis, Pulmonary	2022
The Treatment of Tuberculosis. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:6 Topics: Animals; Antitubercular Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Levofloxacin; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Tuberculosis: clinical trials and new drug regimens. Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3 Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant	2014
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis	2010
Levofloxacin. Tuberculosis (Edinburgh, Scotland), 2008, Volume: 88, Issue:2 Topics: Animals; Antitubercular Agents; Humans; Levofloxacin; Ofloxacin; Treatment Outcome; Tuberculosis	2008

Trials

3 trial(s) available for levofloxacin and Tuberculosis

Article	Year
Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jun-01, Volume: 60, Issue:11 Topics: Adult; Aged; Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Levofloxacin; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tenosynovitis; Transplant Recipients; Treatment Outcome; Tuberculosis	2015
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica AIDS (London, England), 1997, Volume: 11, Issue:12 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis	1997
[Antituberculosis effect of levofloxacin]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2000, Volume: 23, Issue:1 Topics: Adolescent; Adult; Aged; Animals; Antitubercular Agents; Humans; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Tuberculosis	2000

Other Studies

51 other study(ies) available for levofloxacin and Tuberculosis

Article	Year
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8 Topics: Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolones; Thiazoles; Topoisomerase II Inhibitors; Tuberculosis	2010
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy. Bioorganic & medicinal chemistry, 2022, 06-15, Volume: 64 Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells	2022
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru. BMC research notes, 2021, Nov-14, Volume: 14, Issue:1 Topics: Antitubercular Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peru; Pharmaceutical Preparations; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant Current drug delivery, 2023, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant	2023
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study. The Lancet. Global health, 2022, Volume: 10, Issue:7 Topics: Adult; Antitubercular Agents; Child; HIV Infections; Humans; Levofloxacin; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Topics: Antitubercular Agents; Child; Humans; Levofloxacin; Pilot Projects; Tuberculosis; World Health Organization	2022
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen. The American journal of case reports, 2022, Oct-10, Volume: 23 Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis	2022
Determining in vitro and ex vivo protein binding of levofloxacin and moxifloxacin in patients with TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022, 12-01, Volume: 26, Issue:12 Topics: Humans; Levofloxacin; Moxifloxacin; Protein Binding; Tuberculosis	2022
[The problem of formation of new risks of medicinal resistance of patients with tuberculosis in condition of active use of antibiotics by population under COVID-19]. Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny, 2023, Volume: 31, Issue:2 Topics: Anti-Infective Agents; Antitubercular Agents; Azithromycin; COVID-19; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Mycobacterium tuberculosis; Pandemics; Quinolones; Tuberculosis	2023
Protein binding investigation of first-line and second-line antituberculosis drugs. International journal of antimicrobial agents, 2023, Volume: 62, Issue:6 Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis	2023
Determination of minimum bactericidal concentration, in single or combination drugs, against Future microbiology, 2020, Volume: 15 Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis	2020
Levofloxacin based non-rifampicin anti-tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting. Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Developing Countries; Drug Costs; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; India; Kidney Transplantation; Levofloxacin; Male; Middle Aged; Opportunistic Infections; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Tuberculosis; Young Adult	2021
Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis. Current drug delivery, 2021, Volume: 18, Issue:6 Topics: Chitosan; Drug Carriers; Drug Liberation; Humans; Levofloxacin; Nanoparticles; Particle Size; Tuberculosis	2021
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020, 12-01, Volume: 24, Issue:12 Topics: Adolescent; Anti-Bacterial Agents; Aza Compounds; Child; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Tuberculosis	2020
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger. BMJ case reports, 2021, Feb-19, Volume: 14, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Resistance, Multiple; Ethambutol; Female; Fingers; Humans; Levofloxacin; Linezolid; Magnetic Resonance Imaging; Tendons; Tenosynovitis; Tuberculosis; Young Adult	2021
Case Report: Primary Tuberculosis of the Bilateral Breast. The American journal of tropical medicine and hygiene, 2017, Volume: 97, Issue:6 Topics: Adult; Antitubercular Agents; Breast Diseases; Cefuroxime; Debridement; Diagnosis, Differential; Drainage; Female; Humans; Levofloxacin; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis	2017
Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report. Transplantation proceedings, 2018, Volume: 50, Issue:3 Topics: Antitubercular Agents; Humans; Isoniazid; Levofloxacin; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Rifampin; Tuberculosis	2018
In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates. Tuberkuloz ve toraks, 2018, Volume: 66, Issue:1 Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey	2018
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis. American journal of respiratory and critical care medicine, 2013, Jul-01, Volume: 188, Issue:1 Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Levofloxacin; Mice; Mice, Inbred BALB C; Moxifloxacin; Ofloxacin; Pyrazinamide; Quinolines; Treatment Outcome; Tuberculosis	2013
Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Case-Control Studies; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Tuberculosis	2013
Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:8 Topics: Antitubercular Agents; Argentina; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant	2013
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India. Tropical medicine & international health : TM & IH, 2013, Volume: 18, Issue:9 Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis	2013
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method. Tuberculosis (Edinburgh, Scotland), 2013, Volume: 93, Issue:6 Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Oxazines; Tuberculosis; Tuberculosis, Multidrug-Resistant; Xanthenes	2013
Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs. The Journal of antibiotics, 2014, Volume: 67, Issue:11 Topics: Antitubercular Agents; Base Sequence; Colorimetry; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Rifabutin; Rifampin; Sequence Analysis, DNA; Tuberculosis	2014
[Prospective analysis of adverse reactions with long-term levofloxacin use]. Kekkaku : [Tuberculosis], 2014, Volume: 89, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthralgia; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Tuberculosis	2014
[Survey on arthritic pain experienced during the use of levofloxacin--a follow-up survey on the arthritic patients having participated in the "Survey on the use of levofloxacin used to treat tuberculosis" by the Therapeutic Committee, the Japanese Society Kekkaku : [Tuberculosis], 2014, Volume: 89, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthralgia; Data Collection; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Tuberculosis	2014
Reply to Tien et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Nov-15, Volume: 61, Issue:10 Topics: Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Male; Tenosynovitis; Tuberculosis	2015
Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Nov-15, Volume: 61, Issue:10 Topics: Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Male; Tenosynovitis; Tuberculosis	2015
Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015, Volume: 19, Issue:10 Topics: Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis	2015
[Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, May-25, Volume: 67, Issue:5 Topics: Alanine Transaminase; Antitubercular Agents; Cycloserine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Hepatitis, Autoimmune; Humans; Isoniazid; Levofloxacin; Liver; Prothionamide; Severity of Illness Index; Tuberculosis; Young Adult	2016
Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa. Journal of clinical microbiology, 2009, Volume: 47, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carrier State; Child; Child, Preschool; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Mutation, Missense; Ofloxacin; Pneumococcal Infections; Sequence Analysis, DNA; Serotyping; South Africa; Streptococcus pneumoniae; Tuberculosis	2009
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jun-01, Volume: 48, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Antitubercular Agents; Aspartate Aminotransferases; Aza Compounds; Ethambutol; Female; Fluoroquinolones; Hepatic Insufficiency; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Streptomycin; Treatment Outcome; Tuberculosis; Young Adult	2009
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. Journal of clinical microbiology, 2009, Volume: 47, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis	2009
Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10 Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Spain; Tuberculosis	2011
[Evaluation of tuberculosis treatment including levofloxacin (LVFX) in cases who could not continue standard regimen]. Kekkaku : [Tuberculosis], 2011, Volume: 86, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis; Tuberculosis, Pulmonary	2011
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA, Bacterial; DNA, Superhelical; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis; Mycobacterium tuberculosis; Ofloxacin; Plasmids; Tuberculosis	2012
[Efficacy and tolerance of rezonizate in complex with fluoroquinolones or mycobutin on a model of experimental murine tuberculosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:7-8 Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Therapy, Combination; Drug Tolerance; Fluoroquinolones; Gatifloxacin; Isoxazoles; Levofloxacin; Mice; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Rifabutin; Tuberculosis	2011
gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Alleles; China; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis	2012
[The outcome of a survey on the use of levofloxacin for the treatment of tuberculosis]. Kekkaku : [Tuberculosis], 2012, Volume: 87, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Data Collection; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis	2012
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. International journal of antimicrobial agents, 2002, Volume: 20, Issue:6 Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis	2002
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2002, Volume: 33, Issue:3 Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis	2002
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2 Topics: Anti-Infective Agents; DNA Gyrase; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Polymorphism, Single-Stranded Conformational; Reverse Transcriptase Polymerase Chain Reaction; Tuberculosis	2004
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. International journal of antimicrobial agents, 2005, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2005
Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest, 2005, Volume: 128, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Case-Control Studies; Child; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis	2005
In vitro activity of ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and gatifloxacin against multidrug-resistant Mycobacterium tuberculosis in Rio de Janeiro Brazil. Medecine et maladies infectieuses, 2007, Volume: 37, Issue:5 Topics: AIDS-Related Opportunistic Infections; Brazil; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis	2007
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:6 Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Isomerism; Isoniazid; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Splenomegaly; Survival Rate; Tuberculosis	1995
Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4 Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Colony Count, Microbial; Drug Combinations; Ethambutol; Levofloxacin; Mice; Mycobacterium avium; Ofloxacin; Roxithromycin; Spleen; Tuberculosis	1996
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice]. Kekkaku : [Tuberculosis], 1997, Volume: 72, Issue:8 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Clarithromycin; Diclofenac; Drug Therapy, Combination; Female; Levofloxacin; Mice; Mice, Inbred BALB C; Mycobacterium avium; Ofloxacin; Rifamycins; Tuberculosis	1997
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:1 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Levofloxacin; Lung; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium avium; Ofloxacin; Phagocytosis; Rifamycins; Tuberculosis	1998
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. International journal of antimicrobial agents, 2000, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Cell Line; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins; Tuberculosis	2000
Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population. Pharmacotherapy, 2002, Volume: 22, Issue:6 Topics: Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Ofloxacin; Organ Transplantation; Pyrazinamide; Retrospective Studies; Transplantation Immunology; Tuberculosis	2002